… Parkinson’s disease (PD) have greatly contributed to our understanding of the molecular
pathogenesis of this disease… historical development and future prospects of biochemical studies …

… treatments for Parkinson’s disease patients are reviewed, which form the foundation for an
evaluation of future options to control symptoms and halt progression of the disease. These …

… This study raises the exciting prospect of clinical translation of these approaches if acceptable
levels of efficacy and toxicity can be established. Interestingly, robust outgrowth of fibers …

… internationally about Parkinson's disease. He separated Parkinson's disease from multiple
sclerosis … Early treatments of Parkinson's disease were based on empirical observation, and …

… Parkinson's disease (PD) involves motor symptoms reflecting the progressive degeneration
of dopaminergic neurons in the substantia nigra. However, diagnosis is only enabled late in …

… Deterioration of mitochondrial functions has been widely reported in normal aging as well
as in a spectrum of age-associated neurological diseases, including Parkinson’s disease (PD)…

… well as new and prospective therapies for the disease. The current data suggest that prevention
or early treatment of PD may be the most effective therapeutic strategy. New advances in …

… Parkinson's disease (PD) is a progressive neurodegenerative disorder resulting in severe
disability for people with the disease, unrelenting hardship for family members and caregivers, …

… , and assess the prospects for disease modification. Surgical therapies are not considered.
… 23 showed the use of levodopa increased Unified Parkinson Disease Rating Scale (UPDRS) …

… current clinically approved therapies. To gain a … therapies, and Section 7 discusses novel
preclinical strategies. Finally, we conclude the article in Section 8 detailing the future prospects …